title: Morphological and functional changes of rabbit mesenteric artery cultured with fetal bovine serum.
abstract: The aim of this study was to examine the morphological and functional changes in rabbit mesenteric arterial tissue cultured with fetal bovine serum. In the endothelium-denuded arteries cultured under a serum-free condition for one week (serum-free arteries), morphology of the smooth muscle layer was intact. In the serum-free arteries, high K+ -induced contraction did not change but norepinephrine-induced contraction slightly decreased compared with that in the freshly isolated arteries, whereas the sensitivity to these stimulants was significantly augmented. In the medial layer of the arteries cultured with 10% fetal bovine serum for one week (serum-treated arteries), proliferation, disorientation and death of smooth muscle cells were observed. In the serum-treated arteries, both the amplitude of contractions induced by high K+ and norepinephrine and the sensitivity to these stimulants were significantly reduced compared with those of the serum-free arteries. The reduced norepinephrine-induced contraction in the serum-treated arteries was partially recovered by adding NG-monomethyl-L-arginine (L-NMMA), a nitric oxide (NO) synthase inhibitor, to the assay medium. In alpha-toxin permeabilized arteries, the amplitude of Ca2+ -induced contraction and the sensitivity of the contractile apparatus to Ca2+ were significantly reduced after serum-treatment. These results suggest that chronic serum-treatment of rabbit mesenteric arteries impairs muscle contractility by the morphological and phenotypic changes in smooth muscle cells. NO production in smooth muscle cells is also responsible for the decreased contractility after the serum-treatment.
authors.affiliation: Department of Veterinary Pharmacology, Radio Isotope Center, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Japan. aa77167@mail.ecc.u-tokyo.ac.jp
authors.forename: H
authors.initials: H
authors.lastname: Yamawaki
authors.forename: K
authors.initials: K
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Hori
authors.forename: H
authors.initials: H
authors.lastname: Ozaki
authors.forename: S
authors.initials: S
authors.lastname: Nakamura
authors.forename: H
authors.initials: H
authors.lastname: Nakayama
authors.forename: K
authors.initials: K
authors.lastname: Doi
authors.forename: H
authors.initials: H
authors.lastname: Karaki
mesh_terms: D000818:Animals; D002417:Cattle; D016895:Culture Media, Serum-Free; D004305:Dose-Response Relationship, Drug; D006133:Growth Substances / Q000097:blood* / Q000494:pharmacology*; D008297:Male; D017538:Mesenteric Artery, Superior / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000033:anatomy & histology* / Q000187:drug effects / Q000502:physiology*; D009569:Nitric Oxide / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology; D009924:Organ Culture Techniques / Q000379:methods; D010539:Permeability / Q000187:drug effects; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D010738:Type C Phospholipases / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology
chemical_list: D016895:Culture Media, Serum-Free; D006133:Growth Substances; D014662:Vasoconstrictor Agents; D009569:Nitric Oxide; D010738:Type C Phospholipases; D011188:Potassium; D009638:Norepinephrine